A Paired Double Blind Randomised Comparison of Cavilon Durable Barrier Cream (CDBC) to 10% Glycerine (“Sorbolene”) Cream in the Prophylactic Management of Post-Mastectomy Irradiation Skin Care.

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Related Post

World Radiotherapy Awareness Day promotion at ESTRO26
10 June, 2026

Global cancer community prepares to unite for 2026 World Radiotherapy Awareness Day

LATEST NEWS: 10 June 2026 The global radiation therapy

4 June, 2026

Report showcases a year of impactful research, collaboration and consumer engagement

LATEST NEWS: 4 June 2025 TROG’s latest Annual Research